Comparison of noninvasive photodynamic therapy dosimetry methods using a dynamic model of ALA-PDT of human skin

Physics in Medicine and Biology

Volumn 57, Issue 3, 2012, Pages 825-841

  Liu, Baochang ^a,b   Farrell, Thomas J ^a,b   Patterson, Michael S ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEPTH DEPENDENCE; HUMAN SKIN; INITIAL VALUES; LINEAR CORRELATION; NUMERICAL MODELS; PHOTODYNAMIC THERAPY DOSIMETRY; PROTOPORPHYRIN IX; SKIN SURFACES; TREATMENT CONDITIONS; TREATMENT PARAMETERS;

BLEACHING; CLEANING; FLUORESCENCE; NUMERICAL METHODS; OXYGEN; PHOTOSENSITIZERS; SOLS; SURFACE TREATMENT;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; SINGLET OXYGEN;

ARTICLE; CHEMISTRY; COMPUTER SIMULATION; HUMAN; METHODOLOGY; OPTICS; OXYGEN CONSUMPTION; PATHOLOGY; PHOTOCHEMOTHERAPY; RADIATION EXPOSURE; RADIOGRAPHY; RADIOMETRY; SKIN; SKIN TUMOR; SPECTROFLUOROMETRY; STATISTICAL MODEL;

AMINOLEVULINIC ACID; COMPUTER SIMULATION; HUMANS; MODELS, STATISTICAL; OPTICS AND PHOTONICS; OXYGEN CONSUMPTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RADIOMETRY; SINGLET OXYGEN; SKIN; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE;

EID: 84856108546     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/57/3/825     Document Type: Article

References (29)

1. Boere I A, Robinson D J, de Bruijn H S, Kluin J, Tilanus H W, Sterenborg H J C M and de Bruin R W F 2006 Protoporphyrin IX fluorescence photobleaching and the response of rat Barretts esophagus following 5-aminolevulinic acid photodynamic therapy Photochem. Photobiol. 82 163844 (Pubitemid 46158857)
2. Chabrier-Rosello Y, Foster T H, Perez-Nazario N, Mitra S and Haidaris C G 2005 Sensitivity of Candida albicans germ tubes and biofilms to Photofrin-mediated phototoxicity Antimicrob. Agents Chemother. 49 428895 (Pubitemid 41400976)
3. Cottrell W J, Paquette A D, Keymel K R, Foster T H and Oseroff A R 2008 Irradiance-dependent photobleaching and pain in -aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas Clin. Cancer Res. 14 447583
4. Crilly R J, Cheong W, Wilson B and Spears J R 1997 Forward-adjoint fluorescence model: Monte Carlo integration and experimental validation Appl. Opt. 36 651319 (Pubitemid 127743039)
5. Dysart J S, Patterson M S, Farrell T J and Singh G 2002 Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells Photochem. Photobiol. 75 28995
6. Dysart J S, Singh G and Patterson M S 2005 Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells Photochem. Photobiol. 81 196205 (Pubitemid 40327580)
7. Farrell T J, Wilson B C, Patterson M S and Olivo M C 1998 Comparison of the in vivo photodynamic threshold dose for Photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model Photochem. Photobiol. 68 3949 (Pubitemid 128472726)
8. Finlay J C, Mitra S, Patterson M S and Foster T H 2004 Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms Phys. Med. Biol. 49 483760 (Pubitemid 39489928)
9. Georgakoudi I and Foster H T 1998 Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry Photochem. Photobiol. 67 61225 (Pubitemid 128471939)
10. Hudson J A and Cater D B 1964 An analysis of factors affecting tissue oxygen tension Proc. R. Soc. B 161 24774
11. Josefsen L B and Boyle R W 2008 Photodynamic therapy and the development of metal-based photosensitisers Met. Based Drugs 2008 276109
12. Keene J P, Kessel D, Land E J, Redmond R W and Truscott T G 1986 Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds Photochem. Photobiol. 43 11720
13. Laubach H J, Chang S K, Lee S, Rizvi L, Zurakowski D, Davis S J, Taylor C R and Hasana T 2008 In vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy J. Biomed. Opt. 13 050504
14. Liu B, Farrell T J and Patterson M S 2010 A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen Phys. Med. Biol. 55 591332
15. Liu B, Farrell T J, Patterson M S, Jarvi M T and Wilson B C 2009 A Monte Carlo model of detected singlet oxygen luminescence and photosensitizer fluorescence during ALA-pDT of skin Proc. SPIE 7380 73806W111 (http://www.science.mcmaster.ca/medphys/faculty/22-michael-patterson.html)
16. Mitra S and Foster F H 2005 Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin versus Photofrin Photochem. Photobiol. 81 84959 (Pubitemid 41265050)
17. Niedre M J, Yu C, Patterson M S and Wilson B C 2005 Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-leavulinic acid Br. J. Cancer 92 298304 (Pubitemid 40343145)
18. Robinson D J, de Bruijn H S, van der Veen N, Stringer M R, Brown S B and Star W M 1998 Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect Photochem. Photobiol. 67 1409 (Pubitemid 128471972)
19. Salomatina E, Jiang B, Novak J and Yaroslavsky A N 2006 Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range J. Biomed. Opt. 11 064026
20. Stcker M, Struk A, Altmeyer P, Herde M, Baumgartl H and Lubbers D W 2002 The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis J. Physiol. 538 98594 (Pubitemid 35190088)
21. Tschen E H, Wong D S, Pariser D M, Dunlap F E, Houlihan A and Ferdon M B 2006 Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up Br. J. Dermatol. 155 12629 (Pubitemid 44730005)
22. Valentine R M, Brown C T A, Moseley H, Ibbotson S and Wood K 2011 Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas J. Biomed. Opt. 16 048002
23. Wang K K, Finlay J C, Busch T M, Hahn S M and Zhu T C 2010 Explicit dosimetry for photodynamic therapy macroscopic singlet oxygen modeling J. Biophoton. 3 30418
24. Wang K K, Mitra S and Foster T H 2007 A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy Med. Phys. 34 28293 (Pubitemid 46035250)
25. Wang L, Jacques S L and Zheng L 1995 MCML: Monte Carlo modeling of light transport in multi-layered tissues Comput. Methods Programs Biomed. 47 13146
26. Wang L V, Nordquist R E and Chen W R 1997 Optimal beam size for light delivery to absorption-enhanced tumors buried in biological tissues and effect of multiple-beam delivery: a Monte Carlo study Appl. Opt. 36 828691 (Pubitemid 127688053)
27. Wang W 2005 Oxygen partial pressure in outer layers of skin: simulation using three-dimensional multilayered models Microcirculation 12 195207 (Pubitemid 40485632)
28. Wilson B C and Patterson M S 2008 The physics, biophysics and technology of photodynamic therapy Phys. Med. Biol. 53 R61109
29. Wolf E P, Rieger E and Kerl H 1993 Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinoma, and basal cell carcinomas? J. Am. Acad. Dermatol. 28 1721 (Pubitemid 23019558)